26 studies found for:    hepatitis niaid | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Testing Alhydrogel as a Potential Malaria Vaccine in Mali
Condition: Malaria
Interventions: Biological: Pfs25-EPA;   Biological: Euvax/Hepatitis B vaccine;   Biological: Menatra/Meningococcal Groups A, C, Y, W-135 vaccine;   Biological: Alhydrogel
2 Recruiting Combination Therapy for Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Fixed Dose GS-7977/GS-5885;   Drug: GS-7977 + GS-9669
3 Recruiting Leukapheresis for Research on HCV-Coinfected Patients
Conditions: Hepatitis C;   HIV Infections
Intervention:
4 Recruiting A Phase 2a Study of GS-6624 in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Conditions: Liver Fibrosis;   Hepatitis C;   HIV;   HIV/HCV Co-infection
Intervention: Biological: GS-6624
5 Recruiting Study of Fixed Doses of GS-7977 and GS-5885 in People With HCV and HIV
Conditions: Hepatitis C, Chronic;   Co-Infection
Intervention: Drug: Fixed Dose GS-7997 / GS-5885
6 Not yet recruiting HIV Accelerated Liver Disease in Uganda
Condition: Fibrosis
Intervention:
7 Recruiting Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
Condition: Liver Fibrosis
Intervention:
8 Unknown  Racial Difference in HCV/Host Interactions
Condition: Hepatitis C
Intervention:
9 Recruiting Staged Phase I/II Hepatitis C Prophylactic Vaccine
Condition: Hepatitis C
Interventions: Biological: MVA-NSmut;   Biological: AdCh3NSmut1;   Other: Placebo
10 Unknown  Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
Conditions: Thrombocytopenia;   Hepatitis C;   HIV Infections
Intervention: Drug: Anti-D
11 Recruiting Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Pegylated-Interferon Alfa 2b (PEG-IFN);   Drug: Ribavirin (RBV);   Drug: Boceprevir (BOC)
12 Recruiting Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
Condition: Blood Component Removal
Intervention:
13 Recruiting Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons
Condition: HIV Infection
Intervention:
14 Recruiting Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
15 Recruiting Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Condition: Blood Component Removal
Intervention:
16 Recruiting Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Condition: HIV Infections
Intervention:
17 Recruiting A Phase I Study of Mozobil(Trademark) in the Treatment of Patients With WHIMS
Conditions: WHIMS;   Neutrophil Disorder;   Myelokathexis;   Hypogammaglobulinemia
Intervention: Drug: Mozobil (TM)
18 Recruiting Pathogenesis of Physical Induced Urticarial Syndromes
Conditions: Autoinflammatory Syndromes;   Physical Urticaria
Intervention:
19 Recruiting Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis;   HIV;   Liver Cancer
Intervention:
20 Not yet recruiting Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
Condition: Proteogenomic Monitoring in Liver Transplant Recipients
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results
Indicates status has not been verified in more than two years